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ABSTRACT 
 
Inflammation, oxidative stress, apoptosis and neovascularization are risky parameters which influence 
different phases in the pathogenesis of age related macular degeneration (AMD). Beside other 
mediators, this multitiered and complex event of retinal worsening has been exposed to be 
orchestrated by small non coding RNA fragments that bind to specific mRNAs and modulate their 
post transcriptional regulation and gene expression in retina. Several microRNAs (miRNAs) have 
been revealed which are expressed in retina and influence its functionality. These miRNA fragments 
play significant role in the development and maintenance of photoreceptors hence, dysregulation of 
them may augment severe retinal etiopathology. This comprehensive review summarizes the role and 
relevance of several known miRNAs along with their potential utilities as therapeutic targets in AMD 
pathogenesis. 
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INTRODUCTION 
Age related macular degeneration 
(AMD) is a complex, neurodegenerative 
disease of human retina which progressively 
distorts the central vision due to 
deterioration of macula. 
[1] 
Macula present 
near the middle of retina consists of high 
density of photoreceptors, which help in 
creating central and sharp vision. Clinically, 
AMD results in two forms- dry AMD and 
wet AMD. In dry or atrophic macular 
degeneration, metabolic wastes such as 
esterified lipids, proteins and triglycerides 
commonly known as ‘drusen’ accumulate in 
subretinal pigment epithelium (RPE). These 
intransigent lipoproteins (drusen) 
progressively degenerate RPE and Bruch’s 
membrane hence, contort the central vision. 
In wet AMD, the clearance of drusen along 
with oxidative stress causes inflammasome 
activation and release of growth factors. 
Consequently, new blood vessels are formed 
(neovascularization) which usually bleed 
and form dense macular scars after 
hemorrhage. 
[2]
 
 AMD is responsible for vision loss 
in more than 50 million elderly people in the 
world and contributes towards 9 percent of 
total global blindness. 
[3]
 AMD has become 
a serious health concern because of its 
enormously growing social and economic 
implications in an aging society worldwide. 
For this reason, increasing research efforts 
have been made to understand the molecular 
mechanisms of AMD to find early diagnosis 
and treatment for it. Based on the latest 
evidence, the deregulation of microRNA 
(miRNA) expression has been evolving as a 
significant contributor to neurodegeneration 
by influencing most of the mechanisms 
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responsible for AMD. 
[4] 
Various studies are 
indicating miRNAs as effective therapeutic 
targets in the treatment of AMD. 
[5,6] 
MicroRNAs are involved in a variety of 
fundamental cellular processes such as 
cellular proliferation, development, 
migration, and apoptosis regulation. 
[7] 
These enigmatic fragments are 
evolutionarily conserved, single-stranded 
RNA molecules of 19–25 nucleotides long, 
which do not code for proteins. They 
recognize sequences in the 3’-untranslated 
regions (3’-UTR) of target messenger 
RNAs, and either induce mRNA 
degradationor inhibit their translation. 
[8,9]
 
 It has been convincingly proved that 
miRNAs play imperative role in the 
pathology of several disease processes such 
as vasculogenesis, angiogenesis, hypoxia, 
oxidative stress, and inflammation. 
[10] 
Owing to their contributions scientists 
believe that they can be helpful as 
therapeutic targets. 
[11] 
Although no miRNA 
has been directly associated with AMD 
pathology hitherto, but several of them 
contribute in almost all the critical phases of 
AMD pathology right from the RPE 
deterioration to inflammation upto 
neovascularization and retinal bleeding 
(Table 1). All known miRNAs and their role 
and relevance in different phases of AMD 
pathology has been explored and 
summarized as follows. 
 
DRUSEN ACCUMULATION AND RPE 
DEGRADATION 
Retinal pigment epithelium (RPE) is 
the pigmented cell layer, present outside the 
retina and is firmly attached to the 
underlying choroid and overlying 
photoreceptor cells. It maintains normal 
photoreceptor activity. RPE supplies 
nutrients, removes waste products from 
photoreceptor cells and is responsible for 
visual pigment transport and regeneration. 
[12] 
Thus, any damage to the RPE leads to 
the degeneration of the retina, which may 
cause visual impairment and blindness. 
[12] 
Progressive apoptosis of the RPE in dry 
AMD results in degeneration of the 
photoreceptors and the underlying 
choriocapillaries. 
[13] 
In dry AMD patients, it 
has been revealed that RPE cells have a 
reduced level of Dicer1 that results in 
accumulation of Alu element transcripts and 
causes RPE toxicity. 
[14] 
Dicer 1 helps in 
degradation and digestion of Alu RNAs 
whereby, it indirectly protects against the 
risk of RPE degradation. This indicates that 
the reduced level of Dicer1 is an important 
hallmark of the dry AMD. Furthermore, in 
mice lacking other miRNA processing 
enzymes such as Drosha (Drosha 
Ribonuclease III), DGCR8 (DiGeorge 
syndrome critical region 8) and EIF2C2 
(Eukaryotic Translation Initiation 
Factor2C2), no degeneration of the RPE has 
been observed which suggests that 
downregulation of Dicer 1but not of others’ 
contribute in the pathogenesis of AMD. The 
long double-stranded Alu transcripts are 
constantly produced in the retina. In healthy 
individuals, these toxic RNAs are processed 
into shorter, nontoxic products. But in 
patients with dry AMD, Dicer1 levels are 
greatly reduced, allowing these long 
AluRNAs to accumulate and cause RPE 
degeneration. 
[14] 
A recent study by 
Bhattacharjee and colleagues 
[15] 
reveals that 
increased levels of miRNA-34a might play 
important role in the pathogenesis of AMD 
by downregulating the TREM2 (triggering 
receptor expressed on myeloid cells2) 
protein, which is a waste sensing 
transmembrane protein present in the 
microglial cells of retina. This miRNA plays 
important role in removing drusen from the 
retina. The over expression of miR-133a 
and cyclin D2 has been observed to cause 
photoreceptor degeneration in mice. 
[16] 
It 
has been explored that miRNA-375-3p 
downregulation may trigger activation of 
JAK/STAT pathway and chemokine 
signalling that can damage photoreceptors. 
[16] 
Experiment by Murad et al. has revealed 
that inhibition of miRNA-184 results in the 
upregulation of EZR (ezrin) gene and causes 
downregulation of LAMP-1 (Lysosomal-
associated membrane protein 1)that affects 
the phagocytosis in ARPE -19 (human 
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retinal pigment epithelial cell line) cells in 
mice and disrupts the RPE homeostasis. 
[17] 
 
OXIDATIVE STRESS: AN 
INFLEXIBLE PARAMETER 
 Prolonged exposure to sunlight 
along with lifestyle factors such as tobacco 
smoking and consumption of high 
glycaemic foods, create a high 
predisposition of oxidative burden in the 
retina. This results in progressive and 
premature apoptosis of the RPE cells and 
causes degeneration of the photoreceptors 
and the underlying choriocapillaries. There 
is increased risk for oxidative stress in the 
RPE because of its continuous exposure to 
very high levels of phototoxic blue light and 
high oxygen tension. 
[18] 
Therefore, the RPE 
has evolved an intrinsic antioxidant defense 
network that consists of a variety of 
antioxidant enzymes such as superoxide 
dismutases, glutathione peroxidases, 
glutathione S-transferases and catalase. 
Recently, Haque et al. found that miRNA-
30b maintains the expression of catalase in 
human retinal pigment epithelial cell line 
(ARPE-19). They have reported that this 
miRNA-30b is upregulated under in vitro 
conditions of oxidative stress to ARPE-19 
cells, which in turn inhibit the expression of 
endogenous catalase both at the transcript 
and protein levels. 
[19] 
In contrast, 
antioxidant curcumin (diferuloylmethane) 
that protects RPE cells against oxidative 
stress, significantly alters the expression of 
five miRNAs (miRNA-20a, miRNA-126, 
miRNA-146, miRNA-150, and miRNA-
155) that target vascular-endothelial growth 
factor-A(VEGF-A), platelet-derived growth 
factor β (PDGFβ), nuclear factor-κB (NF-
κB), endothelin-1, and p53 in the ARPE-19 
cells. It has been observed that miRNA-30b 
significantly down regulates after ARPE-19 
cells are treated with curcumin. 
[20] 
Another 
finding shows downregulation of miRNA-
23a, that regulates retinoic acid-induced 
neuronal differentiation through the 
transcription factor Hes-1, which is a target 
for this miRNA and is required for the 
differentiation and longevity of neuronal 
cells. 
[21] 
Kutty and colleagues 
[22] 
found 
another important miRNA-9, whose 
expression is greatly upregulated when 
ARPE-19 cells are incubated with a retinoic 
acid derivative that produces oxidative 
stress conditions in vitro.  
 
INFLAMMASOME FUNCTION AND 
RETINAL INFLAMMATION 
Inflammasomes are large 
multimeric protein conglomerates 
expressed in myeloid cells that play crucial 
role in triggering inflammatory process as 
response of the innate immunity. 
Depending upon the triggering event, 
inflammasomes serve as molecular 
platforms for activation of caspase-1, 
followed by maturation and secretion of 
biologically active molecules such as 
interleukin-1β (IL-1β) and IL-18. The 
innate immune system involves specific 
cells and processes that identify and respond 
to pathogens via pattern recognition 
receptors (PRRs). These receptors are 
capable of detecting both pathogen 
associated molecular patterns (PAMPs) and 
danger associated molecular patterns 
(DAMPs) displayed by either pathogens or 
dead and degraded cells. 
[23] 
The oxidized 
fatty acids and protein adducts in the RPE 
cells act as DAMPs that are targeted by 
PRRs. These receptors consist of 
membrane-bound Toll-like receptors 
(TLRs) and cytosolic NOD-like receptors 
(NLRs) that form large cytoplasmic 
complexes called inflammasomes. 
[23]
 
Among other inflammasomes, NLR family 
pyrin domain containing 3 (NLRP3, also 
known as NALP3 or cryopyrin) has 
engrossed much attention as it senses 
different forms of cell stress earnestly. It 
has been revealed that miRNA-223 is an 
important negative post transcriptional 
regulator of NLRP3 expression. 
[24] 
In 
miR-223 deficient mice, hyperactivation of 
NLRP3 inflammasome expression is 
evident which can be linked to 
dysregulated NLRP3 expression in 
myeloid chambers. 
[25] 
This microRNA 
suppresses the expression of NLRP3 by 
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binding to its 3’ untranslated region, 
translating to reduced expression of 
NLRP3. It has been observed that NLRP3 
modulates the toxic expression of proteins 
present in the drusen and Alu RNA in the 
retina. Furthermore, managing the 
downstream effector cytokines slows down 
the retinal damage in AMD. Deficiency of 
Dicer I ribonuclease type III triggers the 
accumulation of Alu RNA in RPE resulting 
in retinal degradation. 
[14] 
 It has been well known in the 
clinical arena that AMD pathology involves 
chronic inflammatory processes. 
[26] 
RPE 
cells coordinate both innate and adaptive 
immunity as they express complement 
components. On exposure to the pathogens 
or rapidly dying cells, the complement 
system activates and produces numerous 
membrane-attack complexes, which result 
in cell lysis, release of chemokines, 
cytokines and generation of pro-
inflammatory molecules. 
[26] 
Interestingly, 
oxidative stress-induced RPE death tends to 
distort the integrity of RPE and Bruch’s 
membrane, which results in the activation of 
the complement system followed by chronic 
inflammation. 
[27] 
Inflammatory cells, such 
as macrophages and microglia cells, have 
been shown to be involved in the AMD 
lesions. 
[28] 
In these lesions, macrophages 
tend to express angiogenic growth factors 
such as VEGF that plays a crucial role in the 
development of choroidal 
neovascularization (CNV). Therefore, 
research including inflammation-related 
miRNAs in human RPE cells and their 
response to proinflammatory cytokines 
could be of great value in understanding the 
pathogenesis of AMD. Such an 
investigation has been performed which 
reveals that miRNA-146a and miRNA-
146b, can play a role in inflammatory 
processes underlying AMD and other retinal 
degenerative diseases through their ability 
to negatively regulate the NF-κB pathway in 
human RPE. 
[29] 
The results of this study 
also highlight that the increased expression 
of miRNA-155 is evident in RPE cells by 
activating the JAK/STAT signaling 
pathway. 
[22]
 According to a recent study, 
NF-κB-regulated miRNAs, miRNA-9, 
miRNA-125b, miRNA-146a, and miRNA-
155 are upregulated in AMD pathology and 
that miRNA-146a and miRNA-155 target 
the 3’-UTR of complement factor H (CFH), 
thus downregulating CFH expression. 
[30] 
Deficiency of CFH in turn activates 
immune-related signaling that drives 
inflammatory neurodegeneration in the 
brain and retinal tissue. 
 
HYPOXIA AND VEGF 
OVEREXPRESSION 
Normally, the concentration of 
oxygen in RPE cells varies from 3 percent 
to 5 percent; a severe decline below this 
range is referred to as hypoxia. The 
pathological response to hypoxia is 
mediated by hypoxia inducible factors 
(HIFs). 
[31] 
HIFs are the major signaling 
molecules involved in cell proliferation, cell 
survival, angiogenesis, iron and glucose 
metabolism. HIFs are composed of two 
subunits i.e. α and β subunits. α subunit is 
regulated by oxygen and β subunit is 
constitutively expressed in the cells. During 
optimal oxygen concentration, HIF-1α is 
hydroxylated by the enzyme proline 
hydroxylase (PHD) and leads to the 
degradation of HIF-1α. [32] Oxygen plays a 
significant role in hydroxylation by serving 
as a co-factor of proline hydroxylase. But 
when oxygen concentration declines, 
hydroxylation does not occur which results 
in the accumulation of HIF-1α in the 
cytoplasm of the RPE cells. 
[32] 
These 
aggregated HIF-1α move to the nucleus of 
these cells, where they act as transcription 
factors for a central molecule involved in 
choroidal neovascularization, called 
vascular endothelial growth factor (VEGF). 
Increased production of VEGF stimulates 
the abnormal growth of blood vessels in the 
choroid. This process is known as 
angiogenesis. Recent studies have shown 
that miRNA-31 may target and 
downregulates the expression of hypoxia-
inducible factor-1α (HIF-1α) and PDGF-B, 
while miRNA-150 targets and downregulate 
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the expression of PDGF-B and VEGF. 
[31] 
Recently, Zhou and coworkers analyzed the 
miRNA-23∼27∼24 gene cluster and 
revealed that the increased expression of 
miRNA-23 and miRNA-27 is responsible 
for pathological angiogenesis in a laser-
induced CNV mouse Model. 
[33] 
These two 
miRNAs might promote angiogenesis by 
targeting proteins such as Sprouty2 
(SPRY2), Sema6A (Semaphorin 6A), and 
Sema6D (Semaphorin 6D). 
[33] 
In contrast, 
miRNA-24 has been observed to repress 
angiogenesis by simultaneously regulating 
multiple components in the actin related 
cytoskeleton pathways of endothelial cells 
(EC). Studies have shown that miRNA-24 
inhibits angiogenesis by targeting multiple 
members downstream of Rho signaling 
including Pak-4 (Serine/threonine-protein 
kinase), Limk-2 (LIM domain kinase 2), and 
Diaph-1 (Protein diaphanous homolog 1) 
proteins. Similar anti-angiogenic function, 
via the targeting of Rho signaling in ECs 
has been found in case of miRNA-21. Here, 
RhoB silencing through miRNA-21 
overexpression impairs EC migration and 
tubulogenesis, thus providing a possible 
mechanism by which miRNA-21 can inhibit 
angiogenesis in course of CNV. 
[34] 
In 
another experiment, researchers have found 
that miRNA-126 is downregulated in CNV 
mice and this miRNA-126 targets and 
increases the levels of VEGF-A, KDR 
(Kinase Insert Domain Receptor) and 
SPRED-1 (Sprouty-related, EVH1 domain-
containing protein 1). 
[35]
 
 
 
 
CHOROIDAL 
NEOVASCULARIZATION AND 
RETINAL HEMORRHAGE 
Choroidal neovascularization is a 
process which involves the abnormal 
growth of new blood vessels originating 
from choriocapillaris (capillary layer of 
choroid membrane). This vascularization 
may extend upto the photoreceptors layer of 
retina. These blood vessels tend to penetrate 
through Bruch’s membrane and RPE, which 
results in the disruption image making 
ability of retina. 
[36] 
The major stimulatory 
factor involved in developing CNV is 
vascular endothelial growth factor (VEGF). 
Besides VEGF, fibrogen growth factor 
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(FGF), platelet derived growth factor 
(PDGF) and angiopoietin-1 (Ang-1) also 
tend to induce neovascularization. 
[36] 
These 
abnormal blood vessels do not possess 
endothelial tight junctions, which 
predispose them to spontaneous bleeding. A 
fibrous component also coexists with these 
vessels that often contracts and puts 
additional stress on already fragile vessels. 
Consequently, it leads to rupture of these 
vessels in the retina, commonly known as 
hemorrhage. Recently, Wang et al. has 
analyzed that reduced levels of miRNA-93 
is responsible for choroidal 
neovascularization (CNV) in the mice. In 
this study, it is found that miRNA-93 
appears to play a role in regulating VEGF-
A, a known factor involved in CNV. 
[36] 
Another study 
[37] 
has reported that 
expression of miRNA-200a-3p and miRNA-
200b-3p are significantly reduced in AMD 
mice eyes. These miRNAs further 
upregulates zinc finger E-box binding 
homeobox 1, 2 (ZEB 1, ZEB 2) and 
vascular endothelial growth factor receptor 
1 (VEGFR1) genes that cause pathological 
ocular angiogenesis. 
[37] 
It has also been 
exposed that another microRNA, miR-133a-
3p targets Cyclin D2, which is known to 
play role in anti-apoptosis, cell cycle arrest 
and neurogenesis is significantly 
upregulated in retinal vasculature. 
[37] 
 
Table 1. Potential role of known micro-RNAs in the pathogenesis of AMD 
MicroRNAs Expression 
level 
 Effect  Target Species/Model/Tissue type Source 
miRNA-30b Upregulation Inhibition of catalase 
expression at the transcript and 
protein levels 
Catalase Human/in vitro/ARPE-19 under 
an oxidant environment 
19 
miRNA-20a, 
miRNA-126, 
miRNA-150, 
miRNA-155 
Upregulation Protection of RPE cells against 
oxidative stress 
VEGF-A, 
PDGFβ,NF-B, 
Endothelin, p53 
Human/in vitro/ARPE-19 under 
an oxidant environment 
20 
miRNA-23a Downregulation Protection of RPE cells against 
oxidative stress 
Fas Human/in vivo/RPE of donor eyes 
with AMD 
21,40 
miRNA-9 Upregulation Importance in maintaining RPE 
cell function 
CEBPA, 
CEBPB 
Human/in vitro/ARPE-19 cells 
treated with retinoic acid to 
induce oxidative stress conditions 
22,29 
miRNA146a, 
miRNA-146b 
Upregulation Role in inflammatory processes  NF-кB 
signaling 
pathway 
Human/in vitro/ARPE-19 cells 
treated with proinflammatory 
cytokines 
29,30 
 miRNA-155 Upregulation Role in inflammatory processes JAK/STAT 
signaling 
pathway 
Human/in vitro/human RPE cells 
obtained from adult donor eyes 
exposed to inflammatory cytokine 
mix 
22,30 
miRNA-31, 
miRNA-150 
Downregulation Dynamic regulation of 
neovascularization through 
downregulation of expression 
of VEGF, HIF and PDGF-B 
 VEGF, HIF, 
 PDGF-B 
Mouse/in vivo/model of ischemia-
induced retinal neovascularization 
 31 
miRNA-23, 
miRNA-27 
Upregulation Induction of sprouting 
angiogenesis by promoting 
angiogenic signaling 
Sprouty2, 
Sema6A, 
Sema6D 
Mouse/in vivo/model of ischemia-
induced retinal neovascularization 
 33 
miRNA-21, 
miRNA-24 
Downregulation Inhibition of angiogenesis by 
targeting multiple members 
downstream of Rho signaling 
Pak-4,Limk-2, 
Diaph-1 
Mouse/in vivo/model of ischemia-
induced retinal neovascularization 
34 
miRNA-126 Downregulation Regulation of the response of 
endothelial cells to VEGF 
VEGF-
A,KDR,SPRED
-1 
Mouse/in vitro/endothelial cells 35 
miRNA-34a Upregulation Inhibition of TREM-2 protein TREM-2  Mouse/in vitro 15 
miRNA-93 Downregulation Responsible for CNV VEGF-A Mouse/in vitro/endothelial cells 36 
miRNA-125b Upregulation Increased levels of oxidative 
stress and inflammatory 
neurodegenerative conditions 
15-LOX,SYN-2 Mouse/in vitro/endothelial cells 30 
miRNA-200a 
miRNA-200b 
Downregulation Responsible for CNV 
 
ZEB 1, ZEB 2, 
FLT 1 
Mouse/in vitro/endothelial cells 37 
miRNA133a-3p Upregulation Photoreceptor degeneration Cyclin D2 Mouse/in vitro 16 
miRNA-375-3p Downregulation Photoreceptor degeneration Jak 2 Mouse/in vitro 16 
miRNA-184 Downregulation Affects phagocytosis in human 
retinal pigment epithelium 
LAMP-1,Ezrin ARPE-19 under an oxidant 
environment 
17 
Dicer1 Downregulation Alu transcripts accumulation 
and RPE toxicity 
Alu RNAs Human/in vivo/RPE of humans 
with GA 
14 
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MICRORNA TARGET 
IDENTIFICATION 
MicroRNAs are the key regulators 
of gene expression that control the functions 
of many target genes. Therefore, 
manipulation of the expression of specific 
miRNAs which are responsible for causing 
certain complex diseases, may provide 
therapeutic solutions to these diseases. By 
identifying specific targets using 
computational techniques, miRNAs which 
are over-expressed can be inhibited and 
those miRNAs whose expression is very 
low can be revived in a particular disease. 
Several computational approaches have 
recently been developed for the prediction 
of miRNA targets including miRanda, 
TargetScan and PicTar. 
[38] 
Target sites for 
miRNA include three categories: - the 5’- 
dominant canonical site, the 5’- dominant 
seed region and the 3’-compensatory site. 
The seed region comprises a stretch of 7 
nucleotides which begins from either first or 
second nucleotide present at the 5’ end of a 
miRNA. Softwares miRanda, TargetScan 
and PicTar focus on the modulation of the 
seed region within the miRNAs and allow 
them to regulate the expression of their 
corresponding target mRNAs. 
[38] 
 This review highlights that the 
clinical etiology of AMD has a large 
bearing on the epigenetic signals and it 
would be highly relevant to suss out 
knowledge from comprehensive analyses of 
miRNAs that are dreaded culprits in 
inflammation, oxidative stress, angiogenesis 
and other pathways both locally and 
systemically. Future studies should focus on 
site specific and phase specific miRNA 
dysregulation in AMD, for instance miR-
146a and miR-155 mediate inflammation 
and microglial activation in the retina 
against response to stress, whereas miR-
125b and miR-17 regulate apoptosis in 
response to hypoxia induced stress. 
Surveillance studies compiling such roles of 
miRNAs may lead us in the direction of 
effective diagnosis and unsurpassed 
therapeutics for AMD. 
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